Of note, upregulation of miRNA-34a, which is induced by GLS2 through Dicer [17], suppresses antioxidant circuits (SIRT1/PGC-1α/NRF2 pathway) and enhances susceptibility of wild-type p53 cancer cells to ROS [60]. The gene discussed is GLS2; the disease is cancer.